ALCAR Found Very Effective for Treating Depression

December 12, 2017

European researchers reviewed a number of studies testing the effects of ALCAR (N-Acetyl-L-Carnitine) on depression. The reason, according to the researchers, is that a deficiency in brain ALCAR activity appears to play a role in the risk of developing depression. In nine randomized control trials, ALCAR was far better than placebo from improving the symptoms of depression and it significantly reduced symptoms.

In an additional three trials where ALCAR was compared to prescription antidepressants, ALCAR had similar effectiveness to the drugs for reducing depressive symptoms. ALCAR was much safer than the drugs and started to work earlier. ALCAR was most effective in treating depression in older adults.

The study is published in the October 25th. 2017 issue of the journal Psychosomatic Medicine by researchers from the Neuroscience Institute, Aging Branch in Padova, Italy who worked in conjunction with researchers from the Institute of Psychiatry, Psychology, and Neuroscience at Kings College, London along with a number of additional academic research institutions.